FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Endo Pharmaceuticals Calcitonin Salmon Nasal Spray Recall

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 20…

Endo Pharmaceuticals, Inc. · Malvern, PA

Risk level
Class II
Reported by FDA
Apr 5, 2023
Recall ID
D-0475-2023
Check your lot numberHow we source this data

Summary

Endo Pharmaceuticals recalled Calcitonin Salmon Nasal Spray starting Mar 2, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0475-2023 on Apr 5, 2023. Reason: Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.

Product description

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.

Lot numbers, UPCs & expiration codes

Lot #: 34770301, exp. date Mar-23; 34770401, exp. date May-23; 12981201, exp. date Nov-23; 13037201, exp. date Dec-23; 13037301, 13647801, exp. date Feb-24; 13722101, exp. date Mar-24; 13980101, 13980001, exp. date Apr-24; 14461701, 14461801, exp. date Jul-24; 14706201, exp. date Aug-24; 14935601, exp. date Oct-24; 5500131A, 5500132A, exp. date Mar-25

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0475-2023
Classification
Class II
Status
Terminated
Recall initiated
Mar 2, 2023
FDA report date
Apr 5, 2023
Quantity
372,938 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Endo Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0475-2023, exactly as published.

Show all FDA fields
City
Malvern
State
PA
Status
Terminated
Country
United States
Event ID
91802
Address
1400 Atwater Dr
Code information
Lot #: 34770301, exp. date Mar-23; 34770401, exp. date May-23; 12981201, exp. date Nov-23; 13037201, exp. date Dec-23; 13037301, 13647801, exp. date Feb-24; 13722101, exp. date Mar-24; 13980101, 13980001, exp. date Apr-24; 14461701, 14461801, exp. date Jul-24; 14706201, exp. date Aug-24; 14935601, exp. date Oct-24; 5500131A, 5500132A, exp. date Mar-25
Postal code
19355-8701
Report date
Apr 5, 2023
Product type
Drugs
Recall number
D-0475-2023
Classification
Class II
Recalling firm
Endo Pharmaceuticals, Inc.
Product quantity
372,938 bottles
Termination date
Nov 8, 2024
Reason for recall
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Mar 2, 2023
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0475-2023, published Apr 5, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls